West Paces Advisors’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-29
Closed -$253 552
2025
Q1
$253 Hold
29
﹤0.01% 545
2024
Q4
$361 Hold
29
﹤0.01% 533
2024
Q3
$337 Hold
29
﹤0.01% 529
2024
Q2
$308 Hold
29
﹤0.01% 545
2024
Q1
$346 Hold
29
﹤0.01% 560
2023
Q4
$314 Hold
29
﹤0.01% 585
2023
Q3
$286 Sell
29
-34
-54% -$354 ﹤0.01% 507
2023
Q2
$629 Hold
63
﹤0.01% 517
2023
Q1
$606 Sell
63
-757
-92% -$8.39K ﹤0.01% 528
2022
Q4
$9.13K Buy
820
+757
+1,202% +$7.91K ﹤0.01% 359
2022
Q3
$537 Hold
63
﹤0.01% 496
2022
Q2
$660 Sell
63
-35
-36% -$384 ﹤0.01% 539
2022
Q1
$1.07K Buy
+98
New +$1.29K ﹤0.01% 527

Other funds holding VTRS

West Paces Advisors's VTRS Position: Q2 2025 in Review

West Paces Advisors sold out of Viatris (VTRS) in Q2 2025, closing a stake of 29 shares — an estimated $253 sold.

West Paces Advisors first reported a position in VTRS in Q1 2022 and held it in 13 quarters. The position peaked at $9.13K in Q4 2022. 975 funds tracked by Wall St. Rank hold VTRS as of Q2 2025.

  • West Paces Advisors reported no remaining Viatris position as of Q2 2025 after selling out during the quarter.
  • West Paces Advisors sold 29 Viatris shares in Q2 2025, an estimated $253.
  • West Paces Advisors first reported a position in Viatris in Q1 2022 and held it in 13 quarters.
  • West Paces Advisors's Viatris position peaked at $9.13K in Q4 2022.
  • 975 funds tracked by Wall St. Rank held Viatris as of Q2 2025.

Based on West Paces Advisors's 13F filing for Q2 2025, filed 23 Jul 2025.